Northrop Grumman Corporation (NOC)

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Northrop Grumman Corporation (“Northrop Grumman” or “the Company”) (NYSE: NOC). Investors who purchased Northrop Grumman securities are encouraged to obtain additional information and assist the investigation.

The investigation concerns whether Northrop Grumman has violated federal securities laws.

Investigation Details

On April 22, 2025, Northrop Grumman issued a press release announcing its financial results for the first quarter of 2025. Among other items, Northrop Grumman reported revenue of $9.47 billion, representing a 7% year-over-year decline and missing consensus estimates by $480 million. The Company’s results included a charge of $477 million pretax tied to manufacturing updates related to its B-21 bomber program. On a related earnings call, Northrop Grumman’s Chief Executive Officer attributed the “charges on the [B-21 bomber] program” largely to “inflationary factors[.]” On this news, Northrop Grumman’s stock price fell $67.25 per share, or 12.66%, to close at $464.08 per share on April 22, 2025.

What’s Next?

If you are aware of any facts relating to this investigation or purchased Northrop Grumman securities, you can assist this investigation. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660

There is No Cost to You

We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contact

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
332-239-2660 | [email protected]